Animal Models of Retinal Vein Occlusion

被引:33
作者
Khayat, Meiaad [1 ,2 ]
Lois, Noemi [1 ]
Williams, Michael [3 ]
Stitt, Alan W. [1 ]
机构
[1] Queens Univ, Sch Med Dent & Biomed Sci, Wellcome Wolfson Ctr Expt Med, 97 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland
[2] King Abdulaziz Univ, Coll Med, Dept Anat, Rabigh Branch, Jeddah, Saudi Arabia
[3] Queens Univ, Sch Med Dent & Biomed Sci, Ctr Med Educ, Belfast, Antrim, North Ireland
关键词
retinal vein occlusion; retinal vein thrombosis; ischemia; experimental models; animal models; in vivo models; ENDOTHELIAL GROWTH-FACTOR; MACULAR EDEMA SECONDARY; TISSUE-PLASMINOGEN-ACTIVATOR; OPTIC-NERVE HEAD; INTRAVITREAL TRIAMCINOLONE INJECTIONS; EXPERIMENTAL IRIS NEOVASCULARIZATION; PHOTODYNAMIC VENOUS THROMBOSIS; PANRETINAL PHOTO-COAGULATION; MULLER CELL RESPONSES; VASCULAR OCCLUSION;
D O I
10.1167/iovs.17-22788
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To provide a comprehensive and current review on the available experimental animal models of retinal vein occlusion (RVO) and to identify their strengths and limitations with the purpose of helping researchers to plan preclinical studies on RVO. METHODS. A systematic review of the literature on experimental animal models of RVO was undertaken. Medline, SCOPUS, and Web of Science databases were searched. Studies published between January 1, 1965, and March 31, 2017, and that met the inclusion criteria were reviewed. The data extracted included animal species used, methods of inducing RVO, and the clinical and histopathologic features of the models, especially in relation to strengths, limitations, and faithfulness to clinical sequelae. RESULTS. A total of 128 articles fulfilling the inclusion criteria were included. Several species were used to model human branch and central RVO (BRVO; CRVO) with nonhuman primates being the most common, followed by rodents and pigs. BRVO and CRVO were most commonly induced by laser photocoagulation and all models showed early features of clinical disease, including retinal hemorrhages and retinal edema. These features made many of the models adequate for studying the acute phase of BRVO and CRVO, although macular edema, retinal ischemia, and neovascular complications were observed in only a few experimental animal models (laser-induced model in rodents, pigs, and nonhuman primates, diathermy-induced model in pigs, and following intravitreal injection of PD0325901 in rabbits for BRVO; and in the laser-induced model in rodents, rabbits, and nonhuman primates, diathermyinduced model in nonhuman primates, following permanent ligation of the central retinal vein in nonhuman primates, and with intravitreal injection of thrombin in rabbits for CRVO). CONCLUSIONS. Experimental animal models of RVO are available to study the pathogenesis of this disease and to evaluate diagnostic/prognostic biomarkers and to develop new therapeutics. Data available suggest laser-induced RVO in pigs and rodents to be overall the best models of BRVO and the laser-induced RVO rodents the best model for CRVO.
引用
收藏
页码:6175 / 6192
页数:18
相关论文
共 218 条
  • [1] Evaluation of Ultrasound-Assisted Thrombolysis Using Custom Liposomes in a Model of Retinal Vein Occlusion
    Abdallah, Walid F.
    Patel, Hitenkumar
    Grant, Edward G.
    Diniz, Bruno
    Chader, Gerald J.
    Humayun, Mark S.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (11) : 6920 - 6927
  • [2] Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate
    Adamis, AP
    Shima, DT
    Tolentino, MJ
    Gragoudas, ES
    Ferrara, N
    Folkman, J
    DAmore, PA
    Miller, JW
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (01) : 66 - 71
  • [3] Agarwal LP, 1973, INDIAN J OPHTHALMOL, V1, P298
  • [4] Inhibition of ocular angiogenesis by an adenovirus carrying the human von Hippel-Lindau tumor-suppressor gene in vivo
    Akiyama, H
    Tanaka, T
    Itakura, H
    Kanai, H
    Maeno, T
    Doi, H
    Yamazaki, M
    Takahashi, K
    Kimura, Y
    Kishi, S
    Kurabayashi, M
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (05) : 1289 - 1296
  • [5] Natural course of experimental retinal vein occlusion in rabbit; arterial occlusion following venous photothrombosis
    Ameri, Hossein
    Ratanapakorn, Tanapat
    Rao, Narsing A.
    Chader, Gerald J.
    Humayun, Mark S.
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 246 (10) : 1429 - 1439
  • [6] Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits
    Ameri, Hossein
    Kim, June-Gone
    Ratanapakorn, Tanapat
    Chader, Gerald J.
    Humayun, Mark S.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (02): : 350 - 355
  • [7] [Anonymous], 1984, AM J OPHTHALMOL, V98, P271
  • [8] Apostolopoulos M, 1996, INT OPHTHALMOL, V19, P281
  • [9] ARCHER DB, 1976, T OPHTHAL SOC UK, V96, P210
  • [10] Antithrombotic effect of ticlopidine in an experimental model of retinal vein occlusion
    Arroyo, JG
    Dastgheib, K
    Hatchell, DL
    [J]. JAPANESE JOURNAL OF OPHTHALMOLOGY, 2001, 45 (04) : 359 - 362